Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

Novapsy SA

History from 17 Jun 2023

UID
CHE-303.819.191
Legal form
AG
Canton
VD
Founded
17 Jun 2023
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 114k
28k57k85k114k8 Aug 2025 · CHF 114k2026
  • shares

Record

  1. Company formed

    Founded 17 Jun 2023

    SHAB HR01-1005797238 ↗
  2. Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    100’000 → 113’671.30
    Shares
    — → 1’136’713
    New shares, % of post-step shares
    — (share counts not published)

    Augmentation ordinaire du capital-actions. Nouveau capital-actions entièrement libéré: CHF 113'671.3, divisé en 1'136'713 actions nominatives de CHF 0.10, avec restrictions quant à la transmissibilité selon statuts.

    From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.60 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006404738 ↗
  3. Name changed

    TakeAir SA → Novapsy SA

    SHAB HR02-1006404738 ↗

Published by 8 Oct 2026